Lusutrombopag

Lusutrombopag
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0223-1mg 1 mg

7 - 10 business days*

67.00€
TGM-TQ0223-2mg 2 mg

7 - 10 business days*

97.00€
TGM-TQ0223-5mg 5 mg

7 - 10 business days*

166.00€
TGM-TQ0223-1mL 1 ml

7 - 10 business days*

219.00€
TGM-TQ0223-10mg 10 mg

7 - 10 business days*

266.00€
TGM-TQ0223-25mg 25 mg

7 - 10 business days*

516.00€
TGM-TQ0223-50mg 50 mg

7 - 10 business days*

751.00€
TGM-TQ0223-100mg 100 mg

7 - 10 business days*

1,060.00€
 
Description: Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin... more
Product information "Lusutrombopag"
Description: Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. Target: Thrombopoietin Receptor, Thrombin. Smiles: CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)C(O)=O)c(Cl)c3)n2)c1OC. References: Kim ES, et al. Lusutrombopag: First Global Approval. Drugs. 2016 Jan,76(1):155-8.
Keywords: S-888711, Mulpleta
Supplier: TargetMol
Supplier-Nr: TQ0223

Properties

Application: Targets thrombopoietin receptor (TPOR, MPL, CD110)
MW: 591.55 D
Formula: C29H32Cl2N2O5S

Database Information

CAS : 1110766-97-6| Matching products
KEGG ID : K05082 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Lusutrombopag"
Write a review
or to review a product.
Viewed